Plasmid DNA gene therapy: Studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo

Cancer Gene Therapy

Volumn 3, Issue 3, 1996, Pages 175-185

  Parker, Suezanne E ^a  

^a VICAL INC   (United States)

Author keywords

Cancer; DNA; Gene therapy; IL 2; Immunotherapy; Plasmid

Indexed keywords

DNA; DRUG CARRIER; INTERLEUKIN 2; LIPOSOME; PRIMER DNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL LINE; EXPERIMENTAL MELANOMA; GENE EXPRESSION; GENE THERAPY; GENETICS; HUMAN; IMMUNOLOGY; KINETICS; METHODOLOGY; MOUSE; PLASMID; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ANIMALS; BLOTTING, SOUTHERN; CELL LINE; DNA; DNA PRIMERS; DRUG CARRIERS; GENE EXPRESSION; GENE THERAPY; HUMANS; INTERLEUKIN-2; KINETICS; LIPOSOMES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PLASMIDS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 17144451211     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Asher AL, Mule JJ, Kasid A, et al. Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors. J Immimol. 1991;146:3227-3234.